000 01483 a2200385 4500
005 20250513040951.0
264 0 _c19950505
008 199505s 0 0 eng d
022 _a0022-1899
024 7 _a10.1093/infdis/171.4.897
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChambers, H F
245 0 0 _aAmpicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
_h[electronic resource]
260 _bThe Journal of infectious diseases
_cApr 1995
300 _a897-902 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmpicillin
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAortic Valve
_xmicrobiology
650 0 4 _aDrug Therapy, Combination
_xpharmacology
650 0 4 _aEndocarditis, Bacterial
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMethicillin Resistance
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aRabbits
650 0 4 _aRifampin
_xpharmacology
650 0 4 _aStaphylococcal Infections
_xdrug therapy
650 0 4 _aStaphylococcus aureus
_xdrug effects
650 0 4 _aSulbactam
_xpharmacology
650 0 4 _aVancomycin
_xpharmacology
700 1 _aKartalija, M
700 1 _aSande, M
773 0 _tThe Journal of infectious diseases
_gvol. 171
_gno. 4
_gp. 897-902
856 4 0 _uhttps://doi.org/10.1093/infdis/171.4.897
_zAvailable from publisher's website
999 _c7706218
_d7706218